Has Stephen Milroy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $725 in general payments to Stephen Milroy, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephen Milroy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephen Milroy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephen Milroy, MD

Dermatology · Charleston, WVNPI 1588629166

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Bristol Myers Squibb at 25.2% of the total. Reporting peaked in 2019 at $561 and has fallen 88.4% since, to $65 in 2025. That places this record below the midpoint for dermatology clinicians in WV, where the typical reported total is $2,210.

$725in general payments, 2019–2025

Across 32 payments — averaging $22.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bristol Myers Squibb$183
Dermavant Sciences, Inc.$99
Prugen, Inc. Pharmaceuticals$90
AbbVie$88
Pfizer$76
Organon$40
plus $149 from 6 others

What the payments were for

Food & beverage$725100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bristol Myers Squibb	5	$183
Dermavant Sciences, Inc.	1	$99
Prugen, Inc. Pharmaceuticals	6	$90
AbbVie	4	$88
Pfizer	4	$76
Organon	4	$40
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$35
Mission Pharmacal Company	2	$33
Hill Dermaceuticals, Inc.	1	$25
LEO Pharma Inc.	1	$23
Taro Pharmaceuticals USA, Inc.	1	$21
Johnson & Johnson	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Otezla$125

How this compares

$725 in reported general payments places this provider in the 30th percentile of 39 dermatology providers in West Virginia.

See all dermatology providers in West Virginia →

Medicare billing

Part B allowed, 2024

$80,994

Medicare patients

605

Services billed

1,072

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira(Cf) PenAdalimumab	16	$105,641
Fluorouracil	209	$12,450
Ketoconazole	581	$8,155
Mometasone Furoate	338	$6,574
Betamethasone Dipropionate	144	$6,119
Clobetasol Propionate	145	$5,464
Triamcinolone Acetonide	360	$4,247
Halobetasol Propionate	56	$3,575
Fluocinonide	60	$2,560
Doxycycline Hyclate	191	$1,997
Mupirocin	314	$1,916
Tretinoin	41	$1,848
Clindamycin Phosphate	44	$1,634
Ciclopirox	70	$1,623
Metronidazole	38	$1,466

Paid to pharmacies, not to this prescriber.

Other dermatology in Charleston

Harry ReynoldsCharleston$2K
Kimberly RossiCharleston$157
Charles FranzBridgeport$728K
Rola GharibMorgantown$393K
Amy VaughanBarboursville$24K
Kenneth HardyMorgantown$13K
Gregory LagosSouth Charleston$11K
Suresh MenonMartinsburg$11K
Jeffrey DodsonBridgeport$10K
Sharifeh FarasatBridgeport$9K

See the full list for West Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →